GSK plc - Insider Trading & Ownership

Entity: Company
Location: 79 New Oxford Street, London, United Kingdom
Summary: The estimated value of insider holdings of GSK plc is at least $234M dollars as of October 1, 2024. GSK plc is the 10%+ Owner of Wave Life Sciences Ltd. and owns shares of Wave Life Sciences Ltd. (WVE) stock worth about $134M. GSK plc is the 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $69M. GSK plc is the 10%+ Owner of CVRx, Inc. and owns shares of CVRx, Inc. (CVRX) stock worth about $18.7M. GSK plc is the 10%+ Owner of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $11.7M.
All Insider Reports: All Insider Reports

Ownership of GSK plc

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
WVE	Wave Life Sciences Ltd.	10%+ Owner	$134M	+$22.3M	+20%	Sep 27, 2024
LYEL	Lyell Immunopharma, Inc.	10%+ Owner	$69M			Jun 21, 2021
CVRX	CVRx, Inc.	10%+ Owner	$18.7M			Jul 2, 2021
SPRO	Spero Therapeutics, Inc.	10%+ Owner	$11.7M			Nov 7, 2022
ME	23andMe Holding Co.	10%+ Owner				Jun 16, 2021
INVA	Innoviva, Inc.	10%+ Owner				May 20, 2021
TBPH	Theravance Biopharma, Inc.	Former 10% Owner				Sep 16, 2022

Showing 1 to 7 of 7 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.